I'd like to take the job co lepsze kamagra czy cialis The US-based drug-development services company, which topped analysts’ estimates for earnings per diluted share (ignoring special items) in the latest quarter, has tightened up its EPS guidance for the full year to reflect a more bullish outlook.
